Cargando…
Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients
Autores principales: | Bertrand, Dominique, Lemée, Veronique, Laurent, Charlotte, Lemoine, Mathilde, Hanoy, Mélanie, Le Roy, Frank, Nezam, Dorian, Pruteanu, Diana, Lebourg, Ludivine, Grange, Steven, Plantier, Jean-Christophe, Boyer, Olivier, Guerrot, Dominique, Candon, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149233/ https://www.ncbi.nlm.nih.gov/pubmed/35007383 http://dx.doi.org/10.1111/ajt.16954 |
Ejemplares similares
-
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2021) -
Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients
por: Bertrand, Dominique, et al.
Publicado: (2021) -
Efficacy of anti–SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2022) -
SARS-CoV-2–specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19
por: Bertrand, Dominique, et al.
Publicado: (2021) -
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
por: Patalon, Tal, et al.
Publicado: (2022)